세계 신속 미생물 검사 시장은 광범위한 진단 의약품 산업에서 빠르게 성장하고 있는 분야입니다. 이러한 검사는 감염성 미생물의 조기 발견 및 식별에 중요한 역할을 하며, 신속하고 표적화된 치료 개입을 가능하게 합니다. 이 시장을 주도하는 요인은 감염성 질환 증가, 보다 빠르고 정확한 진단 결과에 대한 요구, 식품 안전에 대한 관심 증가입니다. 시장의 성장은 기술 발전, 현장진단검사(POCT)의 채택 확대, 규제 환경 지원, R&D 투자 확대, 의료비 증가 등 여러 요인에 기인합니다. 신속 미생물 검사 시장 규모는 2025년부터 2033년까지 9.7%의 연평균 복합 성장률(CAGR)로 2024년 53억 2,000만 달러에서 2033년에는 122억 6,000만 달러에 달할 것으로 예측됩니다.
보다 신속하고 정확한 진단 결과에 대한 요구가 신속 미생물 검사에 대한 수요를 견인하고 있습니다. 감염성 질환의 진단 지연은 이환율, 사망률, 의료 비용 증가로 이어집니다. 예를 들어, Clinical Infectious Diseases 저널에 게재된 연구에 따르면 패혈증 진단이 하루 늦어지면 사망률이 7.6% 증가하는 것으로 추정됩니다. 신속 미생물 검사는 기존 방식에 비해 상당한 시간 단축이 가능합니다. 예를 들어, PCR(중합효소연쇄반응)과 같은 분자 검사는 몇 시간 만에 결과를 얻을 수 있어 조기 발견과 적시에 치료 결정을 내릴 수 있습니다. Journal of Clinical Microbiology에 게재된 연구에 따르면, 혈류 감염에 대한 신속 분자진단법을 도입함으로써 항생제 사용을 최적화할 수 있는 것으로 나타났습니다. 환자 1인당 2,016달러의 비용을 절감할 수 있는 것으로 나타났습니다. 기존의 배양 기반 방법은 시간이 오래 걸리고 결정적인 결과가 나오기까지 며칠이 걸립니다. 반면, 신속 미생물 검사는 분자진단 및 면역 측정과 같은 첨단 기술을 활용하여 미생물을 신속하게 검출 및 동정합니다.
신속 미생물 검사는 주로 임상 현장에서 활용되어 왔습니다. 그러나 환경 모니터링, 식품 안전 검사, 의약품 제조, 동물 진단 등 비임상 환경에서의 활용을 확대할 수 있는 큰 기회가 있습니다. 이러한 분야는 신속미생물검사가 제공하는 신속성, 정확성, 편의성의 혜택을 누릴 수 있으며, 새로운 시장 기회를 창출할 수 있습니다.
세계의 신속 미생물 검사 시장에 대해 조사했으며, 시장 개요와 함께 기술별/기법별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.
목차
제1장 서문
제2장 주요 요약
제3장 신속 미생물 검사 시장 : 경쟁 분석
주요 벤더의 시장 포지셔닝
벤더가 채택하는 전략
주요 업계 전략
제4장 신속 미생물 검사 시장 : 매크로 분석과 시장 역학
서론
세계의 신속 미생물 검사 시장 가치, 2023년-2033년
시장 역학
성장 촉진요인과 억제요인의 영향 분석
See-Saw 분석
Porter's Five Forces 모델
PESTEL 분석
제5장 신속 미생물 검사 시장 : 기술별, 2023년-2033년
시장 개요
성장과 매출 분석 : 2024년 vs. 2033년
시장 세분화
핵산 기반 검사
항체 기반 검사
생화학 검사
효소 테스트
유세포분석
중합효소 연쇄반응(PCR)
임피던스법
기타
제6장 신속 미생물 검사 시장 : 방법별, 2023년-2033년
시장 개요
성장과 매출 분석 : 2024년 vs. 2033년
시장 세분화
증식
핵산
생존 능력
제7장 신속 미생물 검사 시장 : 최종사용자별, 2023년-2033년
시장 개요
성장과 매출 분석 : 2024년 vs. 2033년
시장 세분화
식품 및 음료
제약
환경
퍼스널케어
기타
제8장 북미의 신속 미생물 검사 시장 : 2023년-2033년
제9장 영국 및 EU의 신속 미생물 검사 시장 : 2023년-2033년
제10장 아시아태평양의 신속 미생물 검사 시장 : 2023년-2033년
제11장 라틴아메리카의 신속 미생물 검사 시장 : 2023년-2033년
제12장 중동 및 아프리카의 신속 미생물 검사 시장 : 2023년-2033년
제13장 기업 개요
Abbott Laboratories Inc.
Danaher Corporation
Becton Dickinson And Company
Thermo Fisher Scientific Inc.
Merck KGaA
Bruker Corporation
BioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche Ltd.
Neogen Corporation
Siemens Healthineers AG
Charles River Laboratories International Inc.
QIAGEN NV
3M Company
DiaSorin
LSH
영문 목차
영문목차
The global rapid microbiology tests market is a rapidly growing sector within the broader diagnostics industry. These tests play a crucial role in the early detection and identification of infectious microorganisms, enabling prompt and targeted treatment interventions. The market is driven by the increasing prevalence of infectious diseases, the need for faster and more accurate diagnostic results, and the growing focus on food safety. The market growth can be attributed to several factors, including technological advancements, increasing adoption of point-of-care testing (POCT), supportive regulatory environments, growing investments in research and development, and increasing healthcare expenditure. The rapid microbiology tests market is expected to increase at a CAGR of 9.7% from 2025 to 2033, from US$ 5.32 billion in 2024 to US$ 12.26 billion by 2033.
Need for faster and more accurate diagnostic results
The need for faster and more accurate diagnostic results is driving the demand for rapid microbiology tests. Delayed diagnosis of infectious diseases can lead to increased morbidity, mortality, and healthcare costs. For instance, a study published in the Clinical Infectious Diseases journal estimated that a one-day delay in diagnosing sepsis resulted in a 7.6% increase in mortality. Rapid microbiology tests offer significant time savings compared to traditional methods. For example, molecular tests like PCR (polymerase chain reaction) can provide results in a matter of hours, enabling early detection and timely treatment decisions. Rapid diagnostics can lead to cost savings by reducing hospital stays, unnecessary treatments, and the use of broad-spectrum antibiotics. A study published in the Journal of Clinical Microbiology found that implementing rapid molecular diagnostics for bloodstream infections resulted in cost savings of $2,016 per patient by optimizing antibiotic use. Traditional culture-based methods can be time-consuming, requiring several days to yield conclusive results. In contrast, rapid microbiology tests leverage advanced technologies such as molecular diagnostics and immunoassays to detect and identify microorganisms swiftly.
Expansion of applications in non-clinical settings
Rapid microbiology tests have primarily been utilized in clinical settings. However, there is a significant opportunity to expand their applications in non-clinical settings, such as environmental monitoring, food safety testing, pharmaceutical manufacturing, and veterinary diagnostics. These sectors can benefit from the speed, accuracy, and convenience offered by rapid microbiology tests, presenting new market opportunities.
Limited adoption in resource-constrained settings
One significant restraint for rapid microbiology tests is their limited adoption in resource-constrained settings, particularly in low-income countries and regions with inadequate healthcare infrastructure. The cost of implementing these tests, the requirement for trained personnel, and the need for supporting laboratory facilities can pose challenges in resource-limited settings, hindering widespread adoption and accessibility. According to the World Health Organization (WHO), approximately one-third of healthcare facilities in low-income countries do not have access to basic diagnostic services. The lack of laboratory facilities, trained personnel, and funding in resource-constrained settings can hinder the implementation of rapid microbiology tests. A study published in the Journal of Global Antimicrobial Resistance found that the cost of implementing rapid diagnostics can be a major barrier in low-resource settings, where limited healthcare budgets may not accommodate the higher upfront costs.
Market Segmentation by Technology
The nucleic acid based test led the revenues in 2024 in the rapid microbiology tests market due to several reasons. Firstly, nucleic acid-based tests offer high sensitivity and specificity in detecting microorganisms. They utilize molecular techniques such as polymerase chain reaction (PCR) to amplify and detect specific nucleic acid sequences of pathogens. This allows for accurate and reliable identification of microorganisms, even at low concentrations, leading to increased adoption in various industries and healthcare settings. Secondly, nucleic acid-based tests have a wide range of applications in infectious disease diagnosis, environmental monitoring, and food safety. They can detect a diverse array of pathogens, including bacteria, viruses, fungi, and parasites, making them versatile and suitable for different testing requirements. This broad applicability has contributed to their widespread use and revenue generation.
Market Segmentation by End User
The Food & Beverage segment led the revenues in 2024 in the rapid microbiology tests market for several reasons. Firstly, the food and beverage industry is highly regulated and places a strong emphasis on ensuring product safety and quality. Microbiological contamination in food and beverages can lead to foodborne illnesses, product recalls, and damage to brand reputation. Therefore, rigorous microbiological testing is essential to identify and control potential microbial hazards. Secondly, there has been an increasing focus on food safety and quality globally, leading to a higher demand for rapid microbiology tests in the food and beverage industry. Consumers are becoming more conscious of the safety and origin of the food they consume, which has put pressure on manufacturers to implement robust testing protocols. Rapid microbiology tests enable timely detection and monitoring of microbial contamination, allowing companies to take corrective actions promptly and prevent the distribution of contaminated products.
Market Segmentation by Region
APAC (Asia-Pacific) is expected to register the highest compound annual growth rate (CAGR) during the forecast period of 2023 to 2031 in the global rapid microbiology tests market. APAC has a large and rapidly growing population, which leads to an increased demand for healthcare services. The region is witnessing a rise in infectious diseases, foodborne illnesses, and healthcare-associated infections, which has created a need for rapid and accurate microbiology tests. The increasing awareness about the importance of early diagnosis and infection control measures has further fueled the demand for rapid microbiology tests in APAC. There is a growing focus on improving healthcare infrastructure and expanding laboratory facilities in APAC countries. Governments and healthcare organizations are investing in the development of healthcare systems and upgrading laboratory capabilities. This investment facilitates the adoption of advanced testing technologies, including rapid microbiology tests, to enhance disease surveillance, infection control, and patient management.
The leading players in this market are Abbott Laboratories, Inc., Danaher Corporation, Becton, Dickinson And Company, Thermo Fisher Scientific, Inc., Merck KGaA, Bruker Corporation, BioMerieux, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Neogen Corporation, Siemens Healthineers AG, Charles River Laboratories International, Inc., QIAGEN N.V., 3M Company, DiaSorin.
Historical & Forecast Period
This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Rapid Microbiology Tests market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Rapid Microbiology Tests market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Technology
Nucleic Acid Based Test
Antibody Based Test
Biochemical Test
Enzymatic Test
Flow Cytometry Methods
Polymerase Chain Reaction (PCR) Methods
Impedance Methods
Others
Method
Growth
Nucleic Acid
Viability
End User
Food and Beverages
Pharmaceutical
Environmental
Personal Care
Others
Region Segment (2023-2033; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Rapid Microbiology Tests market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2033.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Rapid Microbiology Tests market?
Which is the largest regional market for Rapid Microbiology Tests market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Rapid Microbiology Tests market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Rapid Microbiology Tests market worldwide?
Table of Contents
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Rapid Microbiology Tests Market
2.2. Global Rapid Microbiology Tests Market, By Technology, 2024 (US$ Million)
2.3. Global Rapid Microbiology Tests Market, By Method, 2024 (US$ Million)
2.4. Global Rapid Microbiology Tests Market, By End User, 2024 (US$ Million)
2.5. Global Rapid Microbiology Tests Market, By Geography, 2024 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2024
